Orchestra BioMed Holdings (OBIO) EPS (Basic) (2021 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly EPS (Basic) came in at -$0.33 in Q1 2026, up 32.86% year-on-year from -$0.25 in Q1 2025, and down 345.96% on a QoQ basis from $0.13 in Q4 2025.
Orchestra BioMed Holdings (OBIO) EPS (Basic) (2021 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 6 years of EPS (Basic) data on file, last reported at -$0.33 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 32.86% year-over-year to -$0.33 in Q1 2026; TTM through Mar 2026 was -$0.9, a 55.75% increase from a year earlier, with the FY2025 full-year figure at -$1.11, up 33.08% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.33, down from $0.13 in the prior quarter.
- Over the last five years, EPS (Basic) for OBIO reached as high as $0.13 in Q4 2025 and fell as low as -$0.76 in Q3 2022.
- Historically, EPS (Basic) has averaged -$0.45 across 5 years, with a median of -$0.44 in 2024.
- Across the five-year window, EPS (Basic) sank 12418.95% in 2022 and surged 130.63% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$0.62 in 2022, then jumped by 40.63% to -$0.37 in 2023, then fell by 19.06% to -$0.44 in 2024, then soared by 130.63% to $0.13 in 2025, then slumped by 345.96% to -$0.33 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.33 in Q1 2026, $0.13 in Q4 2025, and -$0.39 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Orchestra BioMed Holdings | 235.83 Mn | 141.43 Mn | 78,000.00 | -0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.33 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | -0.39 |
| Jun 30, 2025 | -0.56 |
| Mar 31, 2025 | -0.49 |
| Dec 31, 2024 | -0.44 |
| Sep 30, 2024 | -0.47 |
| Jun 30, 2024 | -0.70 |
| Mar 31, 2024 | -0.44 |
| Dec 31, 2023 | -0.37 |
| Sep 30, 2023 | -0.62 |
| Jun 30, 2023 | -0.49 |
| Mar 31, 2023 | -0.43 |
| Dec 31, 2022 | -0.62 |
| Sep 30, 2022 | -0.76 |
| Jun 30, 2022 | -0.39 |
| Mar 31, 2022 | -0.26 |
| Dec 31, 2021 | -0.01 |
| Sep 30, 2021 | -0.01 |
| Jun 30, 2021 | -0.01 |